‘ITN’

DYNACOMP. Training the next generation of composite engineers in the era of virtual testing.

The use of polymer based composite materials in aircraft structures has increased dramatically in the last decades and today they represent up to 50% in weight (Airbus A350 and Boeing B787 Dreamliner aircrafts) for wings, fuselage sections and tail surfaces. The driving force for the introduction of these materials in transport has been their contribution to weight reduction and fuel consumption savings, while offering outstanding mechanical properties. However, the use of composite materials in other parts of the planes that could benefit from the low weight, such as the fan blades of engines and/or nacelles, is progressing more slowly. This is partly because, even though some composite materials have shown a good response against strike incidents (bird or ice impact), experts do not yet fully understand why.

Understanding this dynamic behaviour is key for the incorporation of advanced composites in engines such as the Rolls Royce UltraFan™ concept. This engine “could be ready for service from 2025 and will offer at least 25 per cent improvement in fuel burn and emissions against the same baseline[1]. This dramatic increase in performance is expected to be achieved, amongst others, by the replacement of traditional metallic alloys by means of lighter composites. Carbon-titanium blades are one example of the novel components this engine will make use of.

The DYNACOM European Industrial Doctorate, a research endeavor funded by the Marie Skłodowska-Curie actions, aims at achieving the necessary knowledge on the dynamic behavior of composite materials, while contributing to building a new design paradigm in composite materials. The new design paradigm will accelerate the introduction of new composite materials in aeronautical parts that require a good dynamic behavior, such as the fan blades of the engine. As a matter of fact, the traditional trial and error approach currently used in the design of new aeronautical structural parts, requires a vast and expensive experimental testing campaign at coupon, component and (finally) structure level (see the figure below). DYNACOMP aims at reducing the cost and time-to-market associated to this pyramidal testing campaign by adding a bottom level (see the figure below), based on a virtual testing strategy, following a multiscale simulation approach and supported by a reduced and cheap set of mechanical tests at the micro-scale.

In order to achieve this ambitious goal, the DYNACOMP network will offer two Early Stage Researchers (ESRs) a comprehensive training programme with the objective of establishing the new design paradigm introduced in the previous paragraph. Andrea Trevisi and Maria Azzurra, Master’s degree in Materials Engineering by the University of Salento in Italy, are the two ESRs selected to carry out this project (starting in January 2017). Their work will be closely guided and supervised by renewed scientist in multiple disciplines: IMDEA Materials Institute (experts in micro-mechanics and modelling, leading the scientific direction of the project), HEXCEL (a global producer of advanced composites, end user) and Micro Materials (manufacturer of nanomechanical instruments). The quality of the training programme the ESRs will receive along the project will be monitored by Madri+d foundation and by the Technical University of Madrid.

The long-term goal of the DYNACOM project is to stablish a Doctorate programme on the dynamic behaviour of composite materials so that the next generation of composite engineers in the era of virtual testing are incorporated into the labour market.

Test pyramid currently used in aeronautics for the introduction of new materials in structural components. The bottom level represents the novel design paradigm proposed by the DYNACOMP project.

Etiquetas:

15 PUESTOS MSCA para estudiantes Predoctorales

Se acaban de publicar 15 puestos para predoctorales en el marco de una red ETN de las Acciones Marie Sklowdowska-Curie

PROTECTED is a Marie Sklowdowska-Curie Innovative Training Network (MCSA-ITN) with the primary research aim to create an innovative expertise required to manage the human and environmental impacts of endocrine disruptors (EDs) and their mixtures in the food chain, and environment. In total, 15 Early Stage Researchers (ESRs) will be appointed by the PROTECTED consortium for 36 months each.

For more information please visit http://ec.europa.eu/euraxess/index.cfm/jobs/jobDetails/34121041.

 

 

Etiquetas:

Un premio Nobel de Física 2015 y tres proyectos MSCA coordinador por la Universidad Autónoma de Madrid

La Universidad Autónoma de Madrid coordina tres proyectos financiados por la Comisión Europea bajo los programas del 7º Programa Marco y las Acciones Marie Sklodowska-Cuie de Horizonte 2020. Los proyectos están coordinados por Luis Labarga y Belén Gavela, investigadores del Departamento de Física Teórica de la Universidad Autónoma de Madrid y donde participa el reciente Premio Nobel en Física Takaaki Kajita.

El proyecto SKPLUS tiene como objetivo el continuar en el experimento Super-Kamiokande de T. Kajita, las investigaciones hechas por Takaaki Kajita en interacciones de neutrinos.  Super-Kamiokande se encuentra en el Observatorio de Kamioka (prefectura de Gifu, Japón) y pertenece a ICRR (Institute for Cosmic Ray Research, Universidad de Tokio, “Scientific Partner” de SKPLUS y cuyo director es T. Kajita. Además, con SKPLUS nos hemos incorporado a los trabajos de diseño y construcción de nuevos experimentos en el Observatorio de Kamioka: SK-Gd (Super-Kamiokande con Gadolíneo), que va a proporcionar a Super-Kamiokande la fantástica capacidad de distinguir neutrinos de anti-neutrinos, e Hyper-Kamiokande, una nueva generación, con el que aspiran a establecer experimentalmente la violación carga-paridad en el sector leptónico, un propiedad de la naturaleza de enormes e imprevisibles consecuencias.

SKPlus H2020-MSCA-RISE 2014 Grant Agreement number: 641540

IP: Luis Labarga

Duración: 1/12/2014 – 30/11/2018

Financiación UE: 310.500€

Invisibles  invisibles.eu El objetivo de la red “Invisibles” es el estudio de las componentes más misteriosas del cosmos: neutrinos y materia oscura, que a pesar de ser las partículas más abundantes del universo permanecieron ocultas –“invisibles”- hasta muy recientemente debido a que casi no interactúan con la materia ordinaria de la que estamos hechos.

La red “Invisibles” está coordinada por la Universidad Autónoma de Madrid y agrupa once centros europeos (distribuidos en siete países), y otros dieciocho centros repartidos por el resto del mundo. La red incluye algunas de las principales universidades y centros de investigación mundiales así como empresas tecnológicas punteras.

Invisibles FP7 ITN-GA-2011-289442

IP: Belén Gavela

Duración: 1/04/2012 – 31/03/2016

Financiación UE: 3.823.903€

 

InvisiblesPlus  (en proceso de negociación con REA) H2020-MSCA-RISE-2015

IP: Belén Gavela

Duración: fecha de inicio por confirmar

Financiación UE: 2.070.000€

 

Luis A. Labarga Echeverría  (1960), Profesor Titular y actual director del Departamento de Física Teórica de la Universidad Autónoma de Madrid. Doctor en Ciencias Físicas por la U.A.M. en 1987. Físico experimental de altas energías, su investigación ha estado siempre en la punta de la pirámide de la Ciencia. Colisiones Electrón-positrón a 35 y 100 GeV en los laboratorios DESY (Hamburgo, Alemania) y SLAC (Stanford, California). Interacciones electrón-protón también en DESY. Fue responsable de la construcción en la UAM de una parte significativa del calorímetro del detector ATLAS en el CERN, clave en el descubrimiento del Boston de Higgs. En los últimos años sus trabajos se han concentrado en la física de neutrinos, principalmente con el experimento Super-Kamiokande y en el diseño y desarrollo de una nueva generación de detectores. Trabaja también en el experimento español NEXT, en el laboratorio subterráneo de Canfranc, que investiga la naturaleza Majorana del neutrino. (foto: Daniel Muñoz)

 

Belén Gavela  Legazpi licenciada en Física en 1976 por la Universidad Autónoma de Madrid y Doctor por la Universidad Paris VII en 1979 bajo la supervisión del Profesor Lluis Oliver.  Ha desarrollado su carrera investigadora en diferentes instituciones francesas como la Universidad de Paris VII, Paris Sud-XI, Ecole Polytechnique y LAPP Annecy y un puesto permanente en el CNRS en 1981 al que renunció en 1996. También ha desarrollado su carrera investigadora en las Universidades de Harvard y Brandeis (EEUU) y en el CERN (Centro Europeo de Investigaciones Nucleares). Desde 1996 es profesor titular en la Universidad Autónoma de Madrid.

 

Ha sido miembro del Comité SPCS y del Comité de Investigación del CERN de 1998 a 2001, miembro del Consejo Científico P210 en Francia desde 2012 y miembro del Comité de Poliítica Científica del CERN desde 2014. Durante 2015 fue elegida miembro del Search Committee for the new CERN director general.

 

Takaaki Kajita recibió el premio Nobel junto a Arthur B. McDonald, profesor emérito en la Universidad de Queen, en Kingston, Canadá. En 1998 Takaaki Kajita presentó al mundo el descubrimiento en el experimento SuperKamiokande de que los neutrinos que se producen en la atmósfera a partir de los rayos cósmicos oscilan entre dos identidades en su vuelo hacia la Tierra.  Arthur McDonald posteriormente dirigió el experimento que demostró que los neutrinos producidos en el sol no desaparecen en su camino a la Tierra, sino que cambian de identidad antes de llegar al detector SNO.

 

La Academia Real de Ciencias Sueca galardonó a ambos investigadores con el Nobel “por el descubrimiento de las oscilaciones de los neutrinos, que demuestra que éstos tienen una masa, lo que permite comprender el funcionamiento interno de la materia y conocer así mejor el universo”. Según el jurado: “El descubrimiento ha cambiado nuestra forma de entender el funcionamiento interno de la materia y puede ser crucial para nuestra visión del universo”.

Etiquetas:

1 PhD student position available at Spanish National Cardiovascular Research Center (CNIC), Madrid (Spain)

A PhD student position available for Biochemists, Biologists, and students with degrees in other Life Sciences to develop their thesis within the EU Initial Training Network FP7-PEOPLE-2013-ITN CardioNext, a highly multidisciplinary, intersectoral and competitive training programme in cardiovascular research.

Projects:

PhD students will be involved in research projects aimed at improving post-infarction heart remodelling using different gene therapy approaches. Title:¨Macrophage gene therapy for the treatment of post-infarction remodeling.¨

Requirements:

Applicants must have a Master Degree related to the Biomedicine field. Good English communication skills are mandatory. Those who have research experience in miRNA/Cardiology will be given preference.

Elegibility:

Candidates must be in the first four years (full-time equivalent) of their research careers and have not yet been awarded a doctoral degree. In addition, must not have resided or carried out their main activity (work, studies) in Spain for more than 12 months in the 3 years immediately prior to the recruitment date.

Offered:

  •  a 16 months contract to undertake a PhD in biomedicine (with the possibility of extension)
  •  a competitive salary (33,000 – 37,000 € per annum)
  •  integration in a European network of scientific excellence
  •  stays in private companies and partner academic  labs
  •  extensive training in complementary skills
  •  access to state-of-the-art infrastructures.

Starting date: 01/10/2015.

The CNIC provides benefits packages and is an Equal Opportunity Employer. Send CV (including academic record) and a cover letter addressing your qualifications as they pertain to this position, and contact information of three referees to lmanukyan@cnic.es before July 15, 2015. Please quote reference CN10 in the title of your email.

Etiquetas:
Categorias: FP7, ITN

4 Early Stage Researcher Positions. European Industrial Doctorate CardioFunXion

CardioFunXion provides a platform for industrial-clinical-academic collaboration and will be an example of future partnerships in more efficient and auditable clinical image interpretation tools. All partners bring specific expertise: either they produce workstations (PHILIPS), use them (IDIBAPS, CHUC) or contribute to algorithms to be incorporated into them (UPF). By organising and accelerating exchange of knowledge, experience and tools between the different actors, CardioFunXion will consolidate sustainable partnerships. The project will give early-stage researchers (ESRs) the opportunity to be exceptionally well-placed to become key future contributors to the development of advanced imaging techniques for the assessment of cardiovascular disorders, equipping them with multidisciplinary state-of-the-art skills plus awareness and experience in commercial development, contributing to European scientific and commercial capabilities in an area where technological, scientific and clinical developments are very closely linked.

The program is led by:

  • Universitat Pompeu Fabra (PhySense Group: Sensing in Physiology and Biomedicine, Department of Information and Communication Technologies) in Barcelona
  • Philip Research France, Medysis.
  • The Institut de Investigacions Biomediques Agusti Pi i Sunyer (IDIBAPS) in Barcelona and the Centre Hospitalier et Universitaire de Caen are the associated clinical partner. They provide a full immersion in a clinical environment, offering the possibility to understand practical challenges behind problems they are tackling.

Marie Sklodowska-Curie European Industrial Doctorate CardioFunXion: Towards a novel paradigm for cardiac function announces 4 PhD fellowships starting end of 2015. PhD students will be supervised by PIs from UPF and Philips (spending 50% of the time in each), and include the collaboration with the two clinical centers involved

Projects:

  • Longitudinal assessment of cardiac function
  • Fusion of heterogeneous measurements into a physiological plausible patient representation
  • Open reference databases and tools for the multimodal validation of strain
  • Novel approach for evidence based classification of heart failure etiologies

Download Open Positions Document

 

 

 

 

 

Etiquetas:

The European Commission Will Finance the Training of Researchers in Glycoscience

The European Commission has granted funding for an Innovative Training Network within the  Marie Sklodowska-Curie – Horizon 2020 programme, whose goal is to train scientists in biomedical Glycoscience, which focuses on the study of the structural and functional roles of carbohydrates in their biological context. Glycoscience has an increasing impact on many areas of our economy but particularly in biotechnology, health, food and energy, key focus areas also of the Horizon 2020 program.

Illustrative examples for the importance of Glycoscience are the effects of protein glycosylation on efficacy, immunogenicity and circulatory half-life of recombinant therapeutic proteins and the enormous untapped potential of glycan biomarkers in personalized medicine. Most importantly, the therapeutic use of carbohydrate antigens that activate specific receptors on antigen presenting cells like dendritic cells or macrophages shaping the immune response finds wide applications in the development of synthetic vaccines and for the immunotherapy of cancer, allergy and autoimmune diseases.

The IMMUNOSHAPE project, which will be coordinated by CIC biomaGUNE, brings together 14 leading European academic and industrial partners implementing a multidisciplinary and multisectorial training programme in a transnational network in the fields of biomedical glycoscience and its industrial applications. 13 of those centres will host 15 young researchers from different backgrounds, including organic chemistry, biochemistry, structural biology, molecular biology, pharmacy or biophysics. They will develop their PhD projects in areas such as carbohydrate chemistry, chemical synthesis, structural glycobiology, glycotechnology and glyco-functionalization of nanoparticles, among others. The selected candidates will obtain a three-year contract, during which mobility between the 14 institutions in the network will be encouraged in order to enhance synergies between the different participants.

The trained researchers within Immunoshape will be capable of combining state of the art synthesis and the use of cutting-edge technologies to develop the lead structures for highly selective glycan based multivalent immunotherapeutics that may prove useful in treatments for cancer, autoimmune diseases and allergies.

For application procedures, deadlines and further information, please visit www.immunoshape.eu.

Etiquetas:

The European Commission Will Finance the Training of a New Generation of Researchers in Leishmaniasis

The European Commission has granted funding for an Innovative Training Network within the  Marie Sklodowska-Curie – Horizon 2020 programme, whose goal is to form the next generation of scientists that will contribute to the control of leishmaniasis. The EUROLEISH-NET project, which will be coordinated by CRESIB/ISGlobal, is multi- and inter-disciplinary since it includes basic, clinical and translational research to propose integrated solutions in the diagnosis, treatment and prevention of leishmaniasis worldwide. Nine public and private European excellence centres will host 15 young researchers from different backgrounds, including molecular biology, epidemiology, medicine, veterinary and health economy. In addition, 19 institutions or companies in and outside Europe will contribute to the formation of the young trainees by offering research visits and know how.

An important aspect of the Project will be the selection of the students developing the 15 PhD projects that include areas such as drug development, vaccines, diagnostic tools, genetic population studies, vector control and integrated control programmes. The selected candidates will obtain a three-year contract, during which mobility between the 28 institutions in the network will be encouraged in order to enhance synergies between the different participants.

Leishmaniasis is considered a neglected infectious disease by the World Health Organization (WHO) and causes an estimated 1.3 million new cases and between 20,000 and 30,000 deaths every year. The disease is caused by a unicellular parasite of the Leishmania genus, is transmitted by the sand fly bite and affects both humans and domestic animals. Although it is globally distributed in South America, Africa, Asia and Europe, it is particularly prevalent among poor communities of developing countries since the major risk factors are poverty, malnutrition, population mobility, environmental changes and climate change. It is the only endemic neglected tropical disease in Europe, where it is mainly a veterinary problem but represents a public health risk.

Leishmaniasis can be treated and cured. However, global control of the disease requires the development of new strategies and tools that go from the laboratory to the bedside and the community. This is precisely the objective of EUROLEISH-NET.

Further information and applications via www.euroleish.net (deadline for applications 5th April 2015)

Etiquetas:

14 PhD studentships available in TRUSS (Training in Reducing Uncertainty in Structural Safety)

The growth of cities, impacts of climate change and the massive cost of providing new infrastructure provide the impetus for TRUSS (2015-2018, http://trussITN.eu) which aims to maximize the potential of infrastructure that already exists. If flaws in a structure can be identified early, the cost of repair will be vastly reduced, and here an effective monitoring system would allow identifying the optimum time to repair as well as improving structural safety. But safety is difficult to quantify and requires a deep understanding of the uncertainty associated to measurements and models for the structure and loads. For that purpose, TRUSS brings together an intersectoral and multidisciplinary collaboration between 4 Universities, 11 Industry participants and 1 research institute from 5 European countries. The consortium shares expertise and offers training at an advanced level to qualify graduates for dealing with the challenges of an aging infrastructure stock.

 

TRUSS offers highly competitive and attractive salary and working conditions. There are 14 Early Stage Researchers (PhD students) positions starting in August or September 2015. Each position is for a period of 36 months. The recruitment is done on a competitive basis across all applicants for the projects (note host country for eligibility purposes):

  1. Reliability of concrete structures reinforced with braided FRP (Host: UCD, Ireland);
  2. Reduction of uncertainty in assessing concrete strength of existing structures (Host: Ove Arup, Ireland);
  3. Reduction of uncertainty in design of free standing nuclear spent fuel rack (Host: ENSA, Spain);
  4. Optimization of the design of offshore wind turbine towers (Host TCD, Ireland);
  5. Integrity management of ship structures (Host: Lloyd’s Register, United Kingdom);
  6. Residual life assessment and management of ship unloaders (Host: Lloyd’s Register, United Kingdom);
  7. Railway Weigh-In-Motion for bridge safety (Host: FSDL, United Kingdom);
  8. Probabilistic modelling of bridge damage based on damage indicators (Host: Phimeca, France);
  9. Railway bridge condition monitoring and fault diagnostics (Host: UNOTT, United Kingdom);
  10. Assessment of bridge condition and safety based on measured vibration level (Host: UPC, Spain);
  11. Development of optical fibre distributed sensing for SHM of bridges and large scale structures (Host: UPC, Spain);
  12. Bridge damage detection using an instrumented vehicle (Host: UCD, Ireland);
  13. Using truck sensors for road pavement performance investigation (Host: UNOTT, United Kingdom);
  14. Reduction of uncertainty through regularized, automated road inspection (Host: UCD, Ireland).

More information about the application procedure here

ITN website: http://trussitn.eu/

 

Etiquetas:

Nueva version FAQ – ITN 2015

Recientemente se ha publicado una nueva versión delas Preguntas y Respuestas Frecuentes (FAQ) sobre las Innovative Training Networks en su convocatoria 2015. Está disponible en el Portal del Participante de H2020. Puedes descargarte directamente el documento pinchando aquí.

Se mantienen las FAQ de la convocatoria ITN 2014 en el siguiente enlace.

 

 

 

 

Etiquetas:

Departamento de Química de la UAM encabeza un proyecto ITN

El Departamento de Química de la Universidad Autónoma de Madrid lidera una ITN europea (Innovative Training Network), concedida recientemente por la Comisión Europea, dentro del Programa Marie Skłodowska-Curie Actions para el desarrollo de un European Joint Doctorate on Theoretical Chemistry and Computational Modelling (TCCM).

El proyecto está dotado con un presupuesto cercano a los 4 millones de euros para los próximos cuatro años, y participan, además de la UAM, otras 11 universidades europeas: Leuven (Bélgica), Groningen (Holanda), Tolouse (Francia), Perugia (Italia), Viena (Austria), Barcelona, Pisa (Italia), Pierre et Marie Curie (Francia), Porto (Portugal), Valencia y País Vasco, así como las universidades de París-Saclay y de Estocolmo como asociadas. El coordinador de este doctorado europeo es Manuel Yáñez, catedrático del Departamento de Química y coordinador de un Master Erasmus Mundus.

En dicho doctorado europeo participarán también de un modo activo varias empresas punteras de diferentes sectores, en los que la modelización computacional juega un papel fundamental: Glaxo (GSK), Biolitec, Matgas, Simune, PLC system, Master Up, Scientific Computing and Modelling (SCM) y Atria Science. El consorcio cuenta igualmente con la colaboración directa de dos centros de supercomputación europeos, Barcelona Supercomputing Center (BSC) y CINECA (Italia) y del Centre Européen de Calcul Atomiques et Moleculaires (CECAM), en particular a través de sus nodos de Zaragoza (ZCAM) y de Toulouse.

Esta ITN ofertará 15 contratos doctorales para desarrollar otros tantos proyectos en diversas áreas de la modelización: photodynamics, light-harvesting, phototherapy, new molecular materials, drug metabolites, organometallic catalysis, molecular magnetism, gas separation on graphene.

El Departamento de Química de la UAM tiene igualmente presencia puntera en el campo de la investigación, donde el profesor Fernando Martín dirige el proyecto XCHEM (XUV/X-ray lasers for ultrafast electronic control in chemistry) subvencionado con la prestigiosa Advanced Grant del Consejo Europeo de Investigación; y el profesor Manuel Alcamí lidera la Acción COST XLIC (XUV/X-ray light and fast ions for ultrafast chemistry), de la que forman parte más de 100 grupos de investigación europeos.

Etiquetas:
Categorias: EJD, ITN